News

A new report from research and consulting firm GlobalData forecasts the neuropathic pain market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022

A management report from Tufts CSDD, based on an executive roundtable, found that drug companies and their development partners are incorporating business planning earlier in clinical development

Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health

Lisa Henderson recaps Roni Zeiger's keynote from the Partnerships in Clinical Trials conference earlier in April.

Computer-based modeling and simulation has advanced numerous industries, from aeronautics and engineering to meteorology and finance.

Almost all of us have said over the years, "With the things I?ve seen, I should write a book."

Global neuropathic pain treatment market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022

Drug companies and their development partners who are seeking to increase clinical success rates of new drug candidates are developing tools

Certara announced its acquisition of specialty contract research organization Synchrogenix Information Strategies Inc

Purchase adds global regulatory writing and submissionservices to Certara?s drug development consulting expertise

inVentiv Health Clinical has been selected for an osteoarthritis Investigational New Drug Application by IntelliCell BioSciences, Inc

BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.

Perficient announced it has acquired BioPharm Systems, Inc.

The European Medicines Agency is determined to minimize opposition to its next moves on releasing clinical trial data.

Firecrest platform offers unique capabilities for improving the quality, consistency, and compliance of ICH/GCP

ICON announced that TransCelerate has certified its Firecrest GCP training as mutually acceptable for its members.

RAPS announced a new chapter in Taiwan, which is its first in Asia.

EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials

Linking Leaders, host of invitation-only roundtable forums for clinical trial executives, has witnessed the rapid advancement of quality approaches supporting modern clinical trials.

While the biopharmaceutical industry faces challenges in regulation, standardization, and change, CROs are often in the middle of the change.

RAPS has announced the establishment of a new chapter in Taiwan, its first in Asia.

An agreement between ERT and GE Healthcare has the former integrating the latter's QT Guard Plus Algorithm tool

DIA China has appointed biopharmaceutical executive Haijun (Lou) Dong, PhD, as its managing director.

Targeted discussions with key stakeholders in May

EMA has revealed that in early May, it will launch a final round of targeted consultations on its draft policy...

Clinical trial budget development continues to frustrate industry sponsors and investigative sites.

Biopharmaceutical executive Dr. Haijun (Lou) Dong has been named as managing director for DIA China.

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development